Table of Contents Table of Contents
Previous Page  34 / 258 Next Page
Information
Show Menu
Previous Page 34 / 258 Next Page
Page Background

L

in

et al

.:

J

ournal of

AOAC I

nternational

V

ol

.

100, N

o

.

1, 2017 

145

Determination of Biotin in Infant, Pediatric, and Adult

Nutritionals by High-Performance Liquid Chromatography

and Fluorescence Detection: Single-Laboratory Validation,

First Action 2016.11

Q

i

L

in

, Y

i

D

ing

, F

iona

P

oh

, C

hunyan

Z

hang

, S

hang

-J

ing

P

an

,

and

K

aren

J. S

chimpf

Abbott Nutrition Research and Development, 20 Biopolis Way #09-01/02, Singapore 138668

A reversed-phase HPLC method with postcolumn

protein conjugation and fluorescence detection for the

quantitative determination of biotin in infant, pediatric,

and adult nutritionals was developed and evaluated

in a single-laboratory validation (SLV). Sample of

appropriate size is mixed with 2% metaphosphoric

acid to precipitate out the protein. The filtrate is

injected onto a C18 HPLC column in which biotin and

riboflavin are separated with an appropriate mobile

phase. The biotin, after eluting from the column,

binds with the streptavidin fluorescein to become a

fluorescent conjugate. The conjugate is then detected

by fluorescence at

λ

ex

= 495 nm and

λ

em

= 518 nm. A

column switch is used in the method as an option to

shorten the run time from 30 to 15 min, by eluting out

riboflavin at a higher flow rate. In this SLV, a total of

19 AOAC Stakeholder Panel on Infant Formula and

Adult Nutritionals matrixes representing a range of

infant, pediatric, and adult formulas were evaluated

for their biotin content. The analytical range was

1.66–142 μg/100 g reconstituted final product. The

repeatability and intermediate precision ranged

from 0.5 to 3.0% RSD

r

and from 1.3 to 4.5% RSD

iR

,

respectively. Recovery from spiked matrixes varied

from 95 to 111%, and accuracy of quantification using

Standard Reference Material 1849a ranged from 99 to

105%. The LOQ in reconstituted product was estimated

to be 0.8 μg/100 g. The method was approved by the

Expert Review Panel as First Action at the 2016 AOAC

INTERNATIONAL Mid-Year Meeting.

T

heAOAC Stakeholder Panel on Infant Formula andAdult

Nutritionals (SPIFAN) developed

Standard Method

Performance Requirements

(SMPRs

®

) for Biotin in

Infant Formula and Adult/Pediatric Nutritional Formula and

called for reference methods to determine total biotin in all forms

(powders, ready-to-feed liquids, and liquid concentrates) of

infant, adult, and/or pediatric formula for dispute resolution (1).

Biotin is a water-soluble vitamin also known as vitamin B

7

or vitamin H. It functions in important metabolic processes of

carbohydrates, fats, and amino acids. Biotin is a monocarboxylic

acid containing a cyclic urea structure with the sulfur atom in

a thioether linkage; biocytin, the intermediate metabolite of

biotin, is an amide formed from biotin and lysine (Figure 1).

This method is revised from a method published in 2006, in

which SPE was used for sample preparation to remove riboflavin

and HPLC with a fluorescence detector (FD) was used for the

detection of the biotin/streptavidin/fluorescein conjugate formed

during a postcolumn derivatization (2). In this new method, the

SPE clean-up step is omitted from the sample preparation, and

the revised sample preparation involves simple reconstitution,

dilution with methanol/water, and protein precipitation with

metaphosphoric acid. A column switch is used as an option to

elute out riboflavin in a shorter run time.

Biocytin was subjected to the sample preparation condition

and verified to be stable. It eluted out as a well-resolved peak

from the biotin peak using this HPLC method. All of the 19

tested SPIFAN samples were found to be free of biocytin.

To find out the biotin and biocytin content from the potential

inherent biotin conjugates and biocytin conjugates in the

SPIFAN placebo formula, three ways of hydrolysis were

attempted during sample preparation, adapting the protocols

reported by Lahély et al. (3) and Höller et al. (4): (

1

) acidic

hydrolysis with 2 N sulfuric acid in an autoclave at 120°C for

30 min; (

2

) enzymatic digestion in citric buffer with papain at

37°C for 16 h; and (

3

) acidic hydrolysis with 2 N sulfuric acid in

an autoclave at 120°C for 30 min, followed by pH adjustment to

5.7, and enzymatic digestion in citric buffer with papain at 37°C

for 16 h. All of the three tested SPIFAN placebo samples were

found to be free of biotin conjugates or biocytin conjugates.

AOAC Official Method 2016.11

Biotin in Infant, Pediatric, and Adult Nutritionals

High-Performance Liquid Chromatography

and Fluorescence Detection

First Action 2016

A. Principle

The basis of this method is the strong affinity between biotin

and streptavidin. This method is applicable to infant, pediatric,

and adult nutritional products. Samples of appropriate size

are mixed with 2% metaphosphoric acid to precipitate out the

INFANT FORMULA AND ADULT NUTRITIONALS

Received August 11, 2016. Accepted by SG September 09, 2016.

Corresponding author’s e-mail:

qi.lin@abbott.com

This method was approved by the AOAC Expert Review Panel for

SPIFAN Nutrient Methods as First Action.

The Expert Review Panel for SPIFAN Nutrient Methods invites

method users to provide feedback on the First Action methods.

Feedback from method users will help verify that the methods are

fit-for-purpose and are critical for gaining global recognition and

acceptance of the methods. Comments can be sent directly to the

corresponding author or

methodfeedback@aoac.org

.

DOI: 10.5740/jaoacint.16-0257

34